PeptideStack
5.2kquestions
20kanswers
220users

titration

Page 11 of 19 · 456 questions tagged titration.

456 questions · sorted by votes · page 11 of 19

19 votes 3 answers6.1k views
Why can I not compare oral and injectable milligram figures at all, even roughly?

I keep seeing people reason like this: oral semaglutide 14 mg daily is 98 mg a week, injectable is 2.4 mg a week, therefore the oral dose is roughly 40 times higher,…

oral-glp1
oral-glp1

Oral routes for GLP-1 receptor agonism: peptide formulations rescued by absorption enhancers such as SNAC, and true small molecules that need no…

219 questions
semaglutide
semaglutide

A GLP-1 receptor agonist with a fatty-acid-acylated backbone and a roughly one-week half-life, marketed for type 2 diabetes and for weight…

470 questions
dosing-math
dosing-math

The arithmetic itself: milligrams to millilitres to insulin units, concentration after reconstitution, dose per draw, and vial-days per vial. Show…

764 questions
titration
titration

Stepwise dose increases over weeks, why the label schedules exist at all, and what tolerability-driven deviation from a schedule looks like in…

456 questions
asked by noor_alhassan 11k · 4 months ago
19 votes3 answers5.8k views
Is a titration interval of eight weeks better supported than four weeks for semaglutide?

What I have: eight weeks · semaglutide. I would like to know whether this claim survives contact with evidence. If the answer is "nobody has tested that", I would…

titration
titration

Stepwise dose increases over weeks, why the label schedules exist at all, and what tolerability-driven deviation from a schedule looks like in…

456 questions
dose-escalation
dose-escalation

The decision to move up a step: what evidence supports a four-week interval, what happens when you compress it, and how trial protocols handled…

103 questions
clinical-trials
clinical-trials

Reading the primary literature properly: estimands, intention-to-treat versus per-protocol, confidence intervals, absolute versus relative…

745 questions
semaglutide
semaglutide

A GLP-1 receptor agonist with a fatty-acid-acylated backbone and a roughly one-week half-life, marketed for type 2 diabetes and for weight…

470 questions
asked by fiadh_cronin 58k · 25 days ago
19 votes 5 answers4.1k views
How many weeks to steady state for liraglutide on a weekly schedule?

I am asking mechanistically rather than practically — I want the model, not the protocol. I would rather understand the derivation than memorise the outcome. Two…

glp1-mechanism
glp1-mechanism

Receptor-level pharmacology: GLP-1R as a class B GPCR, cAMP and PKA signalling, biased agonism, internalisation and resensitisation, and the…

132 questions
titration
titration

Stepwise dose increases over weeks, why the label schedules exist at all, and what tolerability-driven deviation from a schedule looks like in…

456 questions
dosing-math
dosing-math

The arithmetic itself: milligrams to millilitres to insulin units, concentration after reconstitution, dose per draw, and vial-days per vial. Show…

764 questions
liraglutide
liraglutide

A once-daily GLP-1 receptor agonist and the compound that established the class. Still relevant for its shorter half-life, its paediatric and…

235 questions
asked by petra_hovland 35k · 1 months ago
18 votes 5 answers39k views
What does PIONEER-4 tell me about vomiting at the 7 mg dose?

Setup, so nobody has to ask: PIONEER-4 · vomiting · 7 mg. I would like help reading this properly rather than being told what conclusion to reach. I have the full…

clinical-trials
clinical-trials

Reading the primary literature properly: estimands, intention-to-treat versus per-protocol, confidence intervals, absolute versus relative…

745 questions
vomiting
vomiting

Emesis as a reported adverse event: trial incidence, its relationship to dose escalation rate, dehydration risk, and when it stops being a…

57 questions
titration
titration

Stepwise dose increases over weeks, why the label schedules exist at all, and what tolerability-driven deviation from a schedule looks like in…

456 questions
asked by ben_akintola 10k · 20 months ago
18 votes 3 answers35k views
Is nausea on mazdutide dose-dependent or dose-rate dependent?

Details up front: nausea · mazdutide. The empirical answer seems settled. The explanation does not. If the honest answer is that nobody knows, I would rather hear…

nausea
nausea

The dominant tolerability signal in every trial of the class: incidence, timing relative to a dose step, duration, and the distinction between…

55 questions
titration
titration

Stepwise dose increases over weeks, why the label schedules exist at all, and what tolerability-driven deviation from a schedule looks like in…

456 questions
mazdutide
mazdutide

A GLP-1 and glucagon receptor dual agonist developed primarily in China, with a distinct dose range and a fast-moving publication record.…

237 questions
asked by teodora_ilic 17k · 23 months ago
18 votes 5 answers29k views
Does holding at 0.25 mg for two weeks before escalating reduce constipation?

Stated plainly: 0.25 mg · two weeks · constipation. I keep seeing this stated as a fact with no explanation attached, and unexplained facts make me suspicious. My…

titration
titration

Stepwise dose increases over weeks, why the label schedules exist at all, and what tolerability-driven deviation from a schedule looks like in…

456 questions
constipation
constipation

Slowed transit as a consequence of delayed gastric emptying and reduced intake: incidence figures, fibre and hydration evidence, and why it often…

55 questions
dose-escalation
dose-escalation

The decision to move up a step: what evidence supports a four-week interval, what happens when you compress it, and how trial protocols handled…

103 questions
asked by tare_weight 60k · 16 months ago
18 votes5 answers24k views
What does SURPASS-3 tell me about injection-site erythema at the 10 mg dose?

Setup, so nobody has to ask: SURPASS-3 · injection-site erythema · 10 mg. I have read the primary source rather than the summary, which has left me with more…

clinical-trials
clinical-trials

Reading the primary literature properly: estimands, intention-to-treat versus per-protocol, confidence intervals, absolute versus relative…

745 questions
injection-site-reaction
injection-site-reaction

Local reactions: erythema, induration, pruritus and nodules. Their relationship to injection depth, diluent composition, benzyl alcohol…

49 questions
titration
titration

Stepwise dose increases over weeks, why the label schedules exist at all, and what tolerability-driven deviation from a schedule looks like in…

456 questions
asked by dana_wexler 11k · 12 months ago
18 votes 5 answers23k views
Does holding at 0.5 mg for sixteen weeks before escalating reduce vomiting?

Details up front: 0.5 mg · sixteen weeks · vomiting. I can predict the outcome but I cannot explain it, which means I will get the next case wrong. I would like to…

titration
titration

Stepwise dose increases over weeks, why the label schedules exist at all, and what tolerability-driven deviation from a schedule looks like in…

456 questions
vomiting
vomiting

Emesis as a reported adverse event: trial incidence, its relationship to dose escalation rate, dehydration risk, and when it stops being a…

57 questions
dose-escalation
dose-escalation

The decision to move up a step: what evidence supports a four-week interval, what happens when you compress it, and how trial protocols handled…

103 questions
asked by rae_oyelowo 17k · 14 months ago
18 votes5 answers19k views
Is constipation on liraglutide dose-dependent or dose-rate dependent?

What I have: constipation · liraglutide. This is one of those things that everyone repeats and nobody derives. This matters practically, not just academically,…

constipation
constipation

Slowed transit as a consequence of delayed gastric emptying and reduced intake: incidence figures, fibre and hydration evidence, and why it often…

55 questions
titration
titration

Stepwise dose increases over weeks, why the label schedules exist at all, and what tolerability-driven deviation from a schedule looks like in…

456 questions
liraglutide
liraglutide

A once-daily GLP-1 receptor agonist and the compound that established the class. Still relevant for its shorter half-life, its paediatric and…

235 questions
asked by Dr_Fatima_Belkacem 18k · 2.1 years ago
18 votes 5 answers14k views
Does early satiety at week two of orforglipron usually resolve without a dose change?

The case in front of me: early satiety · two · orforglipron. I am trying to do this correctly the first time rather than learn it by getting it wrong. I have already…

gi-side-effects
gi-side-effects

The gastrointestinal cluster as a whole - nausea, vomiting, diarrhoea, constipation, reflux, early satiety - with trial incidence rates, dropout…

162 questions
titration
titration

Stepwise dose increases over weeks, why the label schedules exist at all, and what tolerability-driven deviation from a schedule looks like in…

456 questions
orforglipron
orforglipron

A non-peptide, orally bioavailable small-molecule GLP-1 receptor agonist studied in the ATTAIN programme. It is not a peptide, which changes…

219 questions
asked by ravenna_pace 14k · 7 months ago
18 votes 2 answers11k views
What does FLOW tell me about reflux at the 1 mg dose?

The case in front of me: FLOW · reflux · 1 mg. The figures are clear enough; the question is what they mean and what they do not. I can supply the numbers if the…

clinical-trials
clinical-trials

Reading the primary literature properly: estimands, intention-to-treat versus per-protocol, confidence intervals, absolute versus relative…

745 questions
gi-side-effects
gi-side-effects

The gastrointestinal cluster as a whole - nausea, vomiting, diarrhoea, constipation, reflux, early satiety - with trial incidence rates, dropout…

162 questions
titration
titration

Stepwise dose increases over weeks, why the label schedules exist at all, and what tolerability-driven deviation from a schedule looks like in…

456 questions
asked by wren_calloway 23k · 11 months ago
18 votes2 answers8.4k views
What does PIONEER-4 tell me about hair thinning at the 25 mg dose?

Numbers first: PIONEER-4 · hair thinning · 25 mg. I can parse the result. I am less sure what it licenses me to conclude. I have deliberately not looked at anyone…

clinical-trials
clinical-trials

Reading the primary literature properly: estimands, intention-to-treat versus per-protocol, confidence intervals, absolute versus relative…

745 questions
hair-loss
hair-loss

Telogen effluvium following rapid weight loss versus a drug-attributable effect: the timing signature that distinguishes them, protein and…

50 questions
titration
titration

Stepwise dose increases over weeks, why the label schedules exist at all, and what tolerability-driven deviation from a schedule looks like in…

456 questions
asked by pip_okonjo 13k · 14 months ago
18 votes 5 answers8.4k views
What does STEP 8 report at the 2.4 mg dose level?

Concretely: STEP 8 · 2.4 mg. The figures are clear enough; the question is what they mean and what they do not. I can supply the numbers if the specifics change the…

clinical-trials
clinical-trials

Reading the primary literature properly: estimands, intention-to-treat versus per-protocol, confidence intervals, absolute versus relative…

745 questions
dosing-math
dosing-math

The arithmetic itself: milligrams to millilitres to insulin units, concentration after reconstitution, dose per draw, and vial-days per vial. Show…

764 questions
titration
titration

Stepwise dose increases over weeks, why the label schedules exist at all, and what tolerability-driven deviation from a schedule looks like in…

456 questions
asked by Dr_Ilse_Vandenberg 113k · 4 months ago
18 votes5 answers8.2k views
What does STEP 2 tell me about reflux at the 2 mg dose?

The case in front of me: STEP 2 · reflux · 2 mg. The figures are clear enough; the question is what they mean and what they do not. I can supply the numbers if the…

clinical-trials
clinical-trials

Reading the primary literature properly: estimands, intention-to-treat versus per-protocol, confidence intervals, absolute versus relative…

745 questions
gi-side-effects
gi-side-effects

The gastrointestinal cluster as a whole - nausea, vomiting, diarrhoea, constipation, reflux, early satiety - with trial incidence rates, dropout…

162 questions
titration
titration

Stepwise dose increases over weeks, why the label schedules exist at all, and what tolerability-driven deviation from a schedule looks like in…

456 questions
asked by tess_amankwah 22k · 15 months ago
18 votes 5 answers7.7k views
Is constipation on tirzepatide dose-dependent or dose-rate dependent?

What I have: constipation · tirzepatide. This is one of those things that everyone repeats and nobody derives. This matters practically, not just academically,…

constipation
constipation

Slowed transit as a consequence of delayed gastric emptying and reduced intake: incidence figures, fibre and hydration evidence, and why it often…

55 questions
titration
titration

Stepwise dose increases over weeks, why the label schedules exist at all, and what tolerability-driven deviation from a schedule looks like in…

456 questions
tirzepatide
tirzepatide

A dual GIP and GLP-1 receptor agonist. Questions here cover the SURPASS and SURMOUNT programmes, the practical differences from a pure GLP-1…

370 questions
asked by Dr_Hanne_Solberg 36k · 5 months ago
18 votes 2 answers7.3k views
If a survodutide dose is missed by seven days, does the ladder reset?

What I have: survodutide · seven days. I am trying to do this correctly the first time rather than learn it by getting it wrong. I have already made one mistake here…

missed-dose
missed-dose

What the label instructions for a missed weekly dose are, why they differ between agents, and what the pharmacokinetics say about drift in an…

41 questions
titration
titration

Stepwise dose increases over weeks, why the label schedules exist at all, and what tolerability-driven deviation from a schedule looks like in…

456 questions
dosing-math
dosing-math

The arithmetic itself: milligrams to millilitres to insulin units, concentration after reconstitution, dose per draw, and vial-days per vial. Show…

764 questions
survodutide
survodutide

A GLP-1 and glucagon receptor dual agonist with a substantial published MASH dataset. Use this tag for its hepatic endpoints, its dose ladder, and…

225 questions
asked by esben_lykke 84k · 2 months ago
18 votes 5 answers5.3k views
Does holding at 12.5 mg for twelve weeks before escalating reduce nausea?

The case in front of me: 12.5 mg · twelve weeks · nausea. I want to know whether this is a real physical effect or an artefact of how it is measured. What prompted…

titration
titration

Stepwise dose increases over weeks, why the label schedules exist at all, and what tolerability-driven deviation from a schedule looks like in…

456 questions
nausea
nausea

The dominant tolerability signal in every trial of the class: incidence, timing relative to a dose step, duration, and the distinction between…

55 questions
dose-escalation
dose-escalation

The decision to move up a step: what evidence supports a four-week interval, what happens when you compress it, and how trial protocols handled…

103 questions
asked by swab_and_wait 13k · 8 months ago
18 votes0 answers2.3k views
How many weeks to steady state for a GLP-1 receptor agonist on a weekly schedule?

I am asking mechanistically rather than practically — I want the model, not the protocol. I can do the algebra. I am not confident about the conversion factors. If…

glp1-mechanism
glp1-mechanism

Receptor-level pharmacology: GLP-1R as a class B GPCR, cAMP and PKA signalling, biased agonism, internalisation and resensitisation, and the…

132 questions
titration
titration

Stepwise dose increases over weeks, why the label schedules exist at all, and what tolerability-driven deviation from a schedule looks like in…

456 questions
dosing-math
dosing-math

The arithmetic itself: milligrams to millilitres to insulin units, concentration after reconstitution, dose per draw, and vial-days per vial. Show…

764 questions
asked by liam_bracken 6.9k · 2 months ago
17 votes5 answers47k views
Does fatigue at week seven of liraglutide usually resolve without a dose change?

For reference: fatigue · seven · liraglutide. I can find plenty of assertions about this and almost no reasoning, which is usually a sign that nobody has checked.…

fatigue
fatigue

Tiredness on treatment: how much is energy deficit, how much is dehydration or electrolyte drift, how much is genuinely drug-attributable, and…

78 questions
titration
titration

Stepwise dose increases over weeks, why the label schedules exist at all, and what tolerability-driven deviation from a schedule looks like in…

456 questions
liraglutide
liraglutide

A once-daily GLP-1 receptor agonist and the compound that established the class. Still relevant for its shorter half-life, its paediatric and…

235 questions
asked by eoin_mcgarry 18k · 2.3 years ago
17 votes 5 answers42k views
If a mazdutide dose is missed by five days, does the ladder reset?

Setup, so nobody has to ask: mazdutide · five days. I can find plenty of assertions about this and almost no reasoning, which is usually a sign that nobody has…

missed-dose
missed-dose

What the label instructions for a missed weekly dose are, why they differ between agents, and what the pharmacokinetics say about drift in an…

41 questions
titration
titration

Stepwise dose increases over weeks, why the label schedules exist at all, and what tolerability-driven deviation from a schedule looks like in…

456 questions
dosing-math
dosing-math

The arithmetic itself: milligrams to millilitres to insulin units, concentration after reconstitution, dose per draw, and vial-days per vial. Show…

764 questions
mazdutide
mazdutide

A GLP-1 and glucagon receptor dual agonist developed primarily in China, with a distinct dose range and a fast-moving publication record.…

237 questions
asked by sample_id 17k · 2.0 years ago
17 votes5 answers36k views
Does vomiting at week seven of liraglutide usually resolve without a dose change?

The specifics, since they change the answer: vomiting · seven · liraglutide. I would like to understand the steps well enough to explain them to someone else. I have…

vomiting
vomiting

Emesis as a reported adverse event: trial incidence, its relationship to dose escalation rate, dehydration risk, and when it stops being a…

57 questions
titration
titration

Stepwise dose increases over weeks, why the label schedules exist at all, and what tolerability-driven deviation from a schedule looks like in…

456 questions
liraglutide
liraglutide

A once-daily GLP-1 receptor agonist and the compound that established the class. Still relevant for its shorter half-life, its paediatric and…

235 questions
asked by low_dead_space 37k · 21 months ago
17 votes 5 answers30k views
What does TRIUMPH-3 tell me about headache at the 12 mg dose?

What I have: TRIUMPH-3 · headache · 12 mg. I can parse the result. I am less sure what it licenses me to conclude. I have deliberately not looked at anyone else’s…

clinical-trials
clinical-trials

Reading the primary literature properly: estimands, intention-to-treat versus per-protocol, confidence intervals, absolute versus relative…

745 questions
titration
titration

Stepwise dose increases over weeks, why the label schedules exist at all, and what tolerability-driven deviation from a schedule looks like in…

456 questions
asked by n_takahashi 29k · 23 months ago
17 votes 4 answers26k views
Is fatigue on orforglipron dose-dependent or dose-rate dependent?

What I am working with: fatigue · orforglipron. I can predict the outcome but I cannot explain it, which means I will get the next case wrong. I would like to know…

fatigue
fatigue

Tiredness on treatment: how much is energy deficit, how much is dehydration or electrolyte drift, how much is genuinely drug-attributable, and…

78 questions
titration
titration

Stepwise dose increases over weeks, why the label schedules exist at all, and what tolerability-driven deviation from a schedule looks like in…

456 questions
orforglipron
orforglipron

A non-peptide, orally bioavailable small-molecule GLP-1 receptor agonist studied in the ATTAIN programme. It is not a peptide, which changes…

219 questions
asked by net_peptide 12k · 2.1 years ago
17 votes 5 answers23k views
Is fatigue on ecnoglutide dose-dependent or dose-rate dependent?

Concretely: fatigue · ecnoglutide. I understand the observation; what I do not understand is the mechanism behind it. I have read the two review articles that come up…

fatigue
fatigue

Tiredness on treatment: how much is energy deficit, how much is dehydration or electrolyte drift, how much is genuinely drug-attributable, and…

78 questions
titration
titration

Stepwise dose increases over weeks, why the label schedules exist at all, and what tolerability-driven deviation from a schedule looks like in…

456 questions
ecnoglutide
ecnoglutide

A long-acting GLP-1 receptor agonist with a cAMP-biased signalling profile. A niche tag, mostly used for mechanism questions about biased agonism…

223 questions
asked by ines_delacruz 16k · 11 months ago